Qu Biologics’ Phase 2 RESTORE trial data presented at 2021 European Crohn’s and Colitis Congress

NEXT STORY
Vyant Bio Announces Issuance of Key Patent for High-Throughput Optical Assay of Human Mixed Cell Population Spheroids
PREV STORY
Global Veterinary Dental Equipment Market Size to Grow at a CAGR of 8.2% from 2021 to 2030
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

BOSTON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical ...

author_avatar
NASDAQ Market News

MEDTECH Receives FDA Clearance for ROSA Spine

MONTPELLIER, France, Jan. 05, 2016 (GLOBE NEWSWIRE) -- MEDTECH (Euronext, FR0010892950 – ROSA), a ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: Tekes issues a partial decision on the company’s rectification request related to Tekes’s claim to capital loan related to the FIT Biotech HIV vaccine project in 2009-2010

FIT BIOTECH OYCompany releaseSeptember 23, 2016 at 16:40 EET        Tekes issues a partial ...

author_avatar
NASDAQ Market News